Last reviewed · How we verify
NCT05205694: ORFCovid
Oral Health in Covid-19 Survivors
trial in COVID-19 in 210 participants. Status unknown.
31 May 2022
Quick facts
| Lead sponsor | University of Belgrade |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 210 |
| Start date | 20 September 2021 |
| Primary completion | 31 May 2022 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across Serbia |
Conditions studied
- COVID-19 — all drugs for COVID-19 →
- Periodontitis — all drugs for Periodontitis →
Sponsor
University of Belgrade
Who can join
18 and older, any sex, with COVID-19 or Periodontitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Aims are to assess periodontal health and salivary stress/ immunity responses in COVID-19 survivors
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Post-viral alterations in periodontal health in individuals recovering from COVID-19.
Roganović J, Barać M, Miličić B, Petrović M, et al · · 2025 · cited 1× · PMID 40917458 · DOI 10.3389/froh.2025.1654029
Verify or expand the search:
- PubMed search for NCT05205694
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19
Currently open trials in the same condition.
- NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
- NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
- NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
- NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
- NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting
Other University of Belgrade trials
Trials by the same sponsor.
- NCT07414433 — Validation of Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma · not yet recruiting
- NCT07337759 — Fetus Programming and Long Active Outcomes, Interaction Between Mother, Placenta and Fetus in Perinatal and Methabolic D · completed
- NCT06885983 — Healing After Augmentation of Alveolar Ridge Using Collagen Membrane · NA · enrolling by invitation
- NCT07378709 — Exploratory Blood-Based Biomarkers in TACE-Treated Hepatocellular Carcinoma · recruiting
- NCT06349382 — CArbohydrate Loading in Aortic Surgery · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05205694 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Belgrade
- Last refreshed: 25 January 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05205694.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing